For more information call (888) LUHS-888.
Kathy S. Albain
Patients ages > 18 years old with the following criteria may be eligible: must have a histologically confirmed diagnosis of node-positive (one to three nodes) invasive breast carcinoma with positive estrogen and/or progesterone receptor status and negative HER-2, as determined by IHC or non-amplified FISH for screening; have undergone axillary staging by sentinel node biopsy or axillary lymph node dissection (ALND). Additional requirements are in the protocol.
The purpose of this study is to find out if the recurrence score can help decide whether participants should receive chemotherapy or not.